What is AstaTech?
Headquartered in Bristol, Pennsylvania, AstaTech has operated as a critical node in the drug discovery and development supply chain since 1996. The firm distinguishes itself through a dual-pronged business model that integrates high-end analytical services with robust bulk manufacturing capacity. By maintaining a comprehensive catalog of chemical products alongside custom synthesis offerings, AstaTech provides a flexible, cost-effective infrastructure for pharmaceutical and biotechnology entities. Their market position is defined by decades of technical expertise, allowing them to navigate the complex regulatory and scientific requirements inherent in modern drug development cycles.
How much funding has AstaTech raised?
AstaTech has raised a total of $759K across 2 funding rounds:
Debt
$350K
Debt
$409K
Debt (2020): $350K with participation from PPP
Debt (2021): $409K led by PPP
Key Investors in AstaTech
PPP
Public-Private Partnership
What's next for AstaTech?
With the infusion of this major strategic investment, AstaTech is positioned to accelerate its operational footprint and enhance its technological infrastructure. The company is expected to prioritize the expansion of its analytical service capabilities, ensuring it remains at the forefront of chemical research innovation. As the pharmaceutical industry continues to demand more agile and reliable outsourcing partners, AstaTech's focus will likely shift toward optimizing its manufacturing throughput and deepening its integration within the global drug discovery pipeline. This capital deployment serves as a catalyst for long-term growth, enabling the firm to sustain its competitive advantage in an increasingly complex global market.
See full AstaTech company page
